Joel Lexchin received his MD from the University of Toronto in 1977 and for the past 27 years has been an emergency physician at the University Health Network. He is currently a Professor in the School of Health Policy and Management at York University and an Associate Professor in the Department of Family and Community Medicine at the University of Toronto. From 1992-94 he was a member of the Ontario Drug Quality and Therapeutics Committee and he was the chair of the Drugs and Pharmacotherapy Committee of the Ontario Medical Association from 1997-99. He has been a consultant for the province of Ontario, various arms of the Canadian federal government, the World Health Organization, the government of New Zealand and the Australian National Prescribing Service. He is the author or co-author of over 140 peer-reviewed articles on topics such as physician prescribing behaviour, pharmaceutical patent issues, the drug approval process and prescription drug promotion.
Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, Vitry AI. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Medicine 2010;7:e1000352.
Lexchin J. One step forward, one step sideways? Expanding research capacity for neglected diseases. BMC International Health and Human Rights 2010;10:20.
Lexchin J. Drug safety and Health Canada: Going, Going… Gone?. International Journal of Risk and Safety in Medicine 2010;22:41-53.
Lexchin J. Pharmaceutical innovation: can we live forever? A commentary on Schnittker and Karandinos. Social Science & Medicine 2010;70:972-3.
Lexchin J, O’Donovan O. Prohibiting or ‘managing’ conflict of interest? A review of policies and procedures in three European drug regulation agencies. Social Science & Medicine 2010;70:643-647